标题
Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 12, Pages 1026-1031
出版商
BMJ
发表日期
2014-08-19
DOI
10.1136/jclinpath-2014-202561
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
- (2015) Qiong Wu et al. Oncotarget
- Transforming Growth Factor- as a Therapeutic Target in Hepatocellular Carcinoma
- (2014) G. Giannelli et al. CANCER RESEARCH
- Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
- (2014) R. Salgia et al. CLINICAL CANCER RESEARCH
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- TGF-beta in CAF-mediated tumor growth and metastasis
- (2014) A. Calon et al. SEMINARS IN CANCER BIOLOGY
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model
- (2013) Fan Cai et al. BMB Reports
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer
- (2013) Johanna C. Bendell et al. Clinical Colorectal Cancer
- HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
- (2013) Shinya Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
- (2013) Yoon-Koo Kang et al. INVESTIGATIONAL NEW DRUGS
- Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis
- (2013) Yida Liao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2013) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomes in tumor microenvironment influence cancer progression and metastasis
- (2013) Christoph Kahlert et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas
- (2013) Koji Shindo et al. Molecular Cancer
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
- (2013) Maria L. Wikberg et al. TUMOR BIOLOGY
- Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
- (2013) Shinsaku Togo et al. Cancers
- Recent Developments in Myofibroblast Biology
- (2012) Boris Hinz et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
- (2012) Richard H. De Boer et al. BREAST CANCER RESEARCH AND TREATMENT
- Fibroblast activation protein
- (2012) Rui Liu et al. CANCER BIOLOGY & THERAPY
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- Microenvironment-mediated resistance to anticancer therapies
- (2012) Oakley C Olson et al. CELL RESEARCH
- Prognostic Impact of Cancer-Associated Stromal Cells in Patients With Stage I Lung Adenocarcinoma
- (2012) Masami Ito et al. CHEST
- Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus
- (2012) Sebastian F. Schoppmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
- (2012) C. J. Ryan et al. CLINICAL CANCER RESEARCH
- Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
- (2012) E. Fischer et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
- (2012) Xuqi Li et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer-associated fibroblasts as targets for immunotherapy
- (2012) Sunitha Kakarla et al. Immunotherapy
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
- (2012) Magali Castells et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors
- (2012) Geoffrey I. Shapiro et al. INVESTIGATIONAL NEW DRUGS
- International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1
- (2012) Giorgio V. Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker
- (2012) Sayaka Yuzawa et al. MEDICAL ONCOLOGY
- Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
- (2012) H. A. Burris et al. MOLECULAR CANCER THERAPEUTICS
- Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
- (2012) W. N. Brennen et al. MOLECULAR CANCER THERAPEUTICS
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Concise Drug Review: Pazopanib and Axitinib
- (2012) R. M. J. M. van Geel et al. ONCOLOGIST
- Tumor stroma as targets for cancer therapy
- (2012) Jing Zhang et al. PHARMACOLOGY & THERAPEUTICS
- MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
- (2012) A. K. Mitra et al. Cancer Discovery
- Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non-Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy
- (2011) F. Yang et al. CANCER RESEARCH
- Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma
- (2011) Xing Hua et al. Diagnostic Pathology
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
- (2011) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug
- (2011) Sichao Huang et al. JOURNAL OF DRUG TARGETING
- Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study
- (2011) Miguel Martin et al. LANCET ONCOLOGY
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability
- (2010) Hsien-Chia Juan et al. APOPTOSIS
- IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients
- (2010) Michal Rajski et al. BMC Medicine
- Breast Carcinoma-Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations
- (2010) A. N. Hosein et al. CANCER RESEARCH
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion
- (2010) K. D. Grugan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
- (2009) Janna Paulsson et al. AMERICAN JOURNAL OF PATHOLOGY
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
- (2009) J Nemunaitis et al. CANCER GENE THERAPY
- Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution
- (2009) I. Campbell et al. CANCER RESEARCH
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- The multifaceted role of periostin in tumorigenesis
- (2009) Kai Ruan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- The TGF-β paradox in human cancer: an update
- (2009) Maozhen Tian et al. Future Oncology
- Podoplanin Expression Identified in Stromal Fibroblasts as a Favorable Prognostic Marker in Patients with Colorectal Carcinoma
- (2009) Takahiro Yamanashi et al. ONCOLOGY
- Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma
- (2009) Agnieszka Kłosowska-Wardęga et al. PLoS One
- Cancer associated fibroblasts in cancer pathogenesis
- (2009) Omar E. Franco et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
- (2009) Masayuki Shimoda et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy?
- (2009) Tamas A. Gonda et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
- (2008) Michèle Sabbah et al. DRUG RESISTANCE UPDATES
- Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells
- (2008) Tom Donnem et al. Journal of Thoracic Oncology
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas
- (2008) Wen Qiu et al. NATURE GENETICS
- Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
- (2008) Kunio Matsumoto et al. PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now